GeoVax Labs
Yahoo Finance • 10 months ago
GeoVax to Participate in Upcoming December Investor Events
ATLANTA, GA, Nov. 29, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its senior... Full story
Yahoo Finance • 10 months ago
GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress
Presentation of Data from Phase 2 Open-Label Study of GEO-CM04S1 Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients ATLANTA, GA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMe... Full story
Yahoo Finance • 10 months ago
Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023
Single-Dose Protection Demonstrated Against Multiple SARS-CoV-2 Variants ATLANTA, GA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines... Full story
Yahoo Finance • 10 months ago
GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update
Significant Progress towards data milestones in Phase 2 Program of GEO-CM04S1, Next-generation COVID-19 vaccine Gedeptin® clinical data from Phase 1/2 study presented at AACR-AHNS Head and Neck Cancer Conference showing safe administratio... Full story
Yahoo Finance • 11 months ago
Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now
MIAMI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023. The Emerging Growth Conference identif... Full story
Yahoo Finance • 11 months ago
GeoVax to Participate in Upcoming November Investor and Industry Events
ATLANTA, GA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that members of... Full story
Yahoo Finance • 11 months ago
GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities
ATLANTA, GA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced an update on key... Full story
Yahoo Finance • 11 months ago
GeoVax Receives Notice of Allowance for Marburg Vaccine Patent
ATLANTA, GA, Oct. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the U.S. P... Full story
Yahoo Finance • 12 months ago
GeoVax Receives Notice of Allowance for HIV Vaccine Patent
ATLANTA, GA, Oct. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the U.S. Pa... Full story
Yahoo Finance • 12 months ago
Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now
MIAMI, Oct. 04, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of Day 2 of the 63rd Emerging Growth Conference on October 5th, 2023. The Emerging Growth Conference identif... Full story
Yahoo Finance • 12 months ago
Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now
MIAMI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 63rd Emerging Growth Conference on October 4th and 5th, 2023. The Emerging Growth Conference identifi... Full story
Yahoo Finance • 12 months ago
GeoVax to Participate in Upcoming October Investor and Industry Events
Company to Provide Updates on Phase 2 Clinical Trials for Next Generation COVID-19 Vaccine and Cancer Immunotherapy Programs ATLANTA, GA, Sept. 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotech... Full story
Yahoo Finance • 12 months ago
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development
ATLANTA, GA and BERLIN, Germany, Sept. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, and ProBioG... Full story
Yahoo Finance • last year
GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference
Preclinical Data for GEO-CM02 Demonstrates Single-Dose Protection Against Multiple SARS-CoV-2 Variants ATLANTA, GA, Sept. 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company develop... Full story
Yahoo Finance • last year
GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients
Data Published From Phase 2 Open-Label Study of GEO-CM04S1 ATLANTA, GA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human vaccines and immunotherapies agains... Full story
Yahoo Finance • last year
GeoVax Presents Corporate Update at the H.C. Wainwright 25th Annual Global Investment Conference
Updates Presented for Gedeptin® and GEO-CM04S1 Phase 2 Clinical Trials ATLANTA, GA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines... Full story
Yahoo Finance • last year
Presenting on the Emerging Growth Conference on September 6 and 7 Register Now
MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 62nd Emerging Growth Conference on September 6 & 7, 2023. The Emerging Growth Conference identifies... Full story
Yahoo Finance • last year
GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Company to Provide Updates on Multiple Phase 2 Clinical Trials for GEO-CM04S1 and Gedeptin® ATLANTA, GA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunothe... Full story
Yahoo Finance • last year
GeoVax to Present at the Emerging Growth Conference on September 6, 2023
Company to Provide Updates on Multiple Phase 2 Clinical Trialsfor its Next-Generation COVID-19 Vaccine and Cancer Immunotherapy Programs ATLANTA, GA, Aug. 29, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX),... Full story
Yahoo Finance • last year
GeoVax Receives Notice of Allowance for Malaria Vaccine Patent
Patent Covers Multiple Component Vaccine for Both Prevention and Treatment ATLANTA, GA, Aug. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccin... Full story
